Harrow Historical Balance Sheet

HROWL Stock

USD 25.39 0.03 0.12%

Trend analysis of Harrow Health 8625 balance sheet accounts such as Total Current Liabilities of 51.8 M or Total Stockholder Equity of 73.9 M provides information on Harrow Health's total assets, liabilities, and equity, which is the actual value of Harrow Health 8625 to its prevalent stockholders. By breaking down trends over time using Harrow Health balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Harrow Health 8625 latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Harrow Health 8625 is a good buy for the upcoming year.

Harrow Health Inventory

11.41 Million

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.

About Harrow Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Harrow Health 8625 at a specified time, usually calculated after every quarter, six months, or one year. Harrow Health Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Harrow Health and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Harrow currently owns. An asset can also be divided into two categories, current and non-current.

Harrow Health Balance Sheet Chart

At this time, Harrow Health's Cash is quite stable compared to the past year. Cash And Short Term Investments is expected to rise to about 86.9 M this year, although the value of Common Stock will most likely fall to about 19.8 K.

Total Assets Total Current Liabilities Cash And Short Term Investments Common Stock Shares Outstanding Property Plant And Equipment Gross

Add Fundamental

Total Assets

Total assets refers to the total amount of Harrow Health assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Harrow Health 8625 books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Harrow Health balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Harrow Health 8625 are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Harrow Health 8625 balance sheet. This account contains Harrow Health investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Harrow Health 8625 fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most accounts from Harrow Health's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Harrow Health 8625 current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health 8625. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.At this time, Harrow Health's Cash is quite stable compared to the past year. Cash And Short Term Investments is expected to rise to about 86.9 M this year, although the value of Common Stock will most likely fall to about 19.8 K.

	2021	2022	2023	2024 (projected)
Total Liabilities	87.4M	130.1M	241.8M	253.8M
Other Stockholder Equity	106.7M	136.7M	204.2M	214.4M

Total Liab Other Stockholder Equity

Harrow Health balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Non Current Liabilities Total	Other Current Assets	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Short Long Term Debt Total	Current Deferred Revenue	Short Term Debt	Net Receivables	Good Will	Short Term Investments	Inventory
Total Assets		0.92	0.98	0.94	0.95	-0.82	0.86	0.9	0.77	0.92	1.0	0.97	0.6	0.95	0.99	0.66	0.48	0.98	-0.27	0.99	0.27	-0.11	0.96	-0.3	0.24	0.99
Other Current Liab	0.92		0.94	0.89	0.98	-0.67	0.63	0.66	0.61	0.81	0.91	0.8	0.4	0.79	0.89	0.35	0.27	0.98	-0.28	0.9	0.13	-0.13	0.99	-0.22	0.16	0.88
Total Current Liabilities	0.98	0.94		0.95	0.96	-0.82	0.77	0.83	0.77	0.93	0.97	0.92	0.6	0.94	0.95	0.58	0.49	0.98	-0.33	0.96	0.34	-0.01	0.98	-0.18	0.29	0.97
Total Stockholder Equity	0.94	0.89	0.95		0.89	-0.75	0.73	0.83	0.78	0.9	0.91	0.9	0.58	0.88	0.89	0.53	0.49	0.93	-0.17	0.89	0.25	0.04	0.92	-0.34	0.44	0.92
Net Debt	0.95	0.98	0.96	0.89		-0.76	0.67	0.73	0.72	0.87	0.94	0.85	0.54	0.84	0.93	0.41	0.43	0.98	-0.32	0.94	0.22	-0.05	0.97	-0.22	0.26	0.93
Retained Earnings	-0.82	-0.67	-0.82	-0.75	-0.76		-0.74	-0.82	-0.94	-0.96	-0.82	-0.84	-0.84	-0.85	-0.81	-0.61	-0.79	-0.76	0.21	-0.82	-0.3	-0.1	-0.72	-0.07	-0.38	-0.87
Cash	0.86	0.63	0.77	0.73	0.67	-0.74		0.95	0.66	0.78	0.88	0.94	0.56	0.9	0.9	0.9	0.45	0.75	-0.17	0.89	0.26	-0.27	0.73	-0.36	0.04	0.85
Cash And Short Term Investments	0.9	0.66	0.83	0.83	0.73	-0.82	0.95		0.82	0.87	0.9	0.98	0.71	0.93	0.91	0.85	0.63	0.78	-0.14	0.9	0.33	-0.07	0.75	-0.38	0.34	0.91
Common Stock Shares Outstanding	0.77	0.61	0.77	0.78	0.72	-0.94	0.66	0.82		0.93	0.76	0.82	0.86	0.8	0.75	0.53	0.85	0.7	-0.07	0.75	0.27	0.2	0.65	-0.07	0.64	0.84
Other Stockholder Equity	0.92	0.81	0.93	0.9	0.87	-0.96	0.78	0.87	0.93		0.91	0.92	0.77	0.92	0.9	0.61	0.7	0.88	-0.22	0.91	0.3	0.08	0.86	-0.08	0.43	0.95
Total Liab	1.0	0.91	0.97	0.91	0.94	-0.82	0.88	0.9	0.76	0.91		0.97	0.6	0.95	1.0	0.68	0.48	0.97	-0.29	1.0	0.28	-0.15	0.96	-0.28	0.19	0.98
Total Current Assets	0.97	0.8	0.92	0.9	0.85	-0.84	0.94	0.98	0.82	0.92	0.97		0.67	0.97	0.97	0.79	0.58	0.89	-0.22	0.97	0.32	-0.09	0.87	-0.35	0.29	0.97
Common Stock	0.6	0.4	0.6	0.58	0.54	-0.84	0.56	0.71	0.86	0.77	0.6	0.67		0.66	0.59	0.51	0.91	0.51	-0.12	0.6	0.4	0.33	0.46	-0.03	0.58	0.68
Accounts Payable	0.95	0.79	0.94	0.88	0.84	-0.85	0.9	0.93	0.8	0.92	0.95	0.97	0.66		0.95	0.81	0.57	0.89	-0.33	0.95	0.43	-0.08	0.87	-0.2	0.26	0.96
Non Current Liabilities Total	0.99	0.89	0.95	0.89	0.93	-0.81	0.9	0.91	0.75	0.9	1.0	0.97	0.59	0.95		0.7	0.47	0.96	-0.28	1.0	0.26	-0.18	0.94	-0.31	0.16	0.98
Other Current Assets	0.66	0.35	0.58	0.53	0.41	-0.61	0.9	0.85	0.53	0.61	0.68	0.79	0.51	0.81	0.7		0.45	0.51	-0.29	0.68	0.46	-0.16	0.5	-0.24	0.03	0.68
Property Plant And Equipment Net	0.48	0.27	0.49	0.49	0.43	-0.79	0.45	0.63	0.85	0.7	0.48	0.58	0.91	0.57	0.47	0.45		0.38	-0.1	0.47	0.4	0.48	0.33	0.01	0.69	0.6
Non Current Assets Total	0.98	0.98	0.98	0.93	0.98	-0.76	0.75	0.78	0.7	0.88	0.97	0.89	0.51	0.89	0.96	0.51	0.38		-0.3	0.96	0.21	-0.12	1.0	-0.25	0.19	0.95
Non Currrent Assets Other	-0.27	-0.28	-0.33	-0.17	-0.32	0.21	-0.17	-0.14	-0.07	-0.22	-0.29	-0.22	-0.12	-0.33	-0.28	-0.29	-0.1	-0.3		-0.28	-0.44	-0.12	-0.32	-0.13	0.07	-0.3
Short Long Term Debt Total	0.99	0.9	0.96	0.89	0.94	-0.82	0.89	0.9	0.75	0.91	1.0	0.97	0.6	0.95	1.0	0.68	0.47	0.96	-0.28		0.26	-0.16	0.95	-0.3	0.18	0.98
Current Deferred Revenue	0.27	0.13	0.34	0.25	0.22	-0.3	0.26	0.33	0.27	0.3	0.28	0.32	0.4	0.43	0.26	0.46	0.4	0.21	-0.44	0.26		0.52	0.21	0.28	0.32	0.31
Short Term Debt	-0.11	-0.13	-0.01	0.04	-0.05	-0.1	-0.27	-0.07	0.2	0.08	-0.15	-0.09	0.33	-0.08	-0.18	-0.16	0.48	-0.12	-0.12	-0.16	0.52		-0.12	0.22	0.62	-0.02
Net Receivables	0.96	0.99	0.98	0.92	0.97	-0.72	0.73	0.75	0.65	0.86	0.96	0.87	0.46	0.87	0.94	0.5	0.33	1.0	-0.32	0.95	0.21	-0.12		-0.25	0.15	0.93
Good Will	-0.3	-0.22	-0.18	-0.34	-0.22	-0.07	-0.36	-0.38	-0.07	-0.08	-0.28	-0.35	-0.03	-0.2	-0.31	-0.24	0.01	-0.25	-0.13	-0.3	0.28	0.22	-0.25		-0.13	-0.27
Short Term Investments	0.24	0.16	0.29	0.44	0.26	-0.38	0.04	0.34	0.64	0.43	0.19	0.29	0.58	0.26	0.16	0.03	0.69	0.19	0.07	0.18	0.32	0.62	0.15	-0.13		0.32
Inventory	0.99	0.88	0.97	0.92	0.93	-0.87	0.85	0.91	0.84	0.95	0.98	0.97	0.68	0.96	0.98	0.68	0.6	0.95	-0.3	0.98	0.31	-0.02	0.93	-0.27	0.32

Click cells to compare fundamentals

Harrow Health Account Relationship Matchups

Harrow Health balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	59.1M	57.5M	98.3M	157.0M	311.8M	327.3M
Other Current Liab	2.4M	1.7M	4.9M	(836K)	27.0M	28.4M
Total Current Liabilities	12.3M	10.8M	9.7M	18.6M	49.3M	51.8M
Total Stockholder Equity	27.7M	27.2M	11.3M	27.2M	70.4M	73.9M
Net Debt	16.2M	19.4M	35.8M	7.9M	116.4M	122.2M
Retained Earnings	(74.0M)	(77.4M)	(95.4M)	(109.5M)	(133.9M)	(127.2M)
Cash	4.7M	4.1M	42.2M	96.3M	74.1M	77.8M
Cash And Short Term Investments	29.9M	32.6M	50.7M	96.3M	82.8M	86.9M
Common Stock Shares Outstanding	26.5M	25.9M	26.8M	27.5M	32.6M	34.2M
Liabilities And Stockholders Equity	59.1M	57.5M	98.3M	157.0M	311.8M	327.3M
Other Stockholder Equity	101.7M	104.6M	106.7M	136.7M	204.2M	214.4M
Total Liab	31.7M	30.6M	87.4M	130.1M	241.8M	253.8M
Total Current Assets	36.8M	40.1M	60.7M	118.3M	139.1M	146.0M
Accounts Payable	7.4M	3.6M	5.2M	18.6M	21.4M	22.5M
Non Current Liabilities Total	19.4M	19.8M	77.7M	111.5M	192.4M	202.0M
Other Current Assets	786K	941K	1.3M	22.0M	9.0M	9.4M
Property Plant And Equipment Net	11.9M	11.3M	9.1M	11.0M	10.3M	5.6M
Non Current Assets Total	22.3M	17.3M	37.7M	37.2M	172.7M	181.3M
Non Currrent Assets Other	7.7M	3.8M	12.4M	4.1K	(2.1M)	(2.0M)
Short Long Term Debt Total	21.0M	23.5M	78.0M	104.9M	190.5M	200.0M
Current Deferred Revenue	57K	66K	16K	113K	75K	71.3K
Short Term Debt	2.4M	5.1M	560K	723K	806K	765.7K
Accumulated Other Comprehensive Income	(2.8M)	(4.4M)	0.0	(409K)	(368.1K)	(386.5K)
Net Receivables	2.7M	2.7M	4.5M	6.4M	36.5M	38.3M
Short Term Investments	25.2M	28.5M	8.5M	5.6M	8.7M	10.8M
Inventory	3.3M	4.0M	4.2M	6.5M	10.9M	11.4M
Intangible Assets	2.3M	1.9M	17.1M	25.8M	162.0M	170.1M
Long Term Debt	12.2M	12.4M	71.7M	104.2M	119.8M	125.8M
Capital Surpluse	101.7M	104.6M	106.7M	137.1M	157.6M	113.7M
Property Plant Equipment	11.9M	11.3M	3.1M	3.5M	3.1M	5.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Harrow Health 8625 is a strong investment it is important to analyze Harrow Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health's future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:

How To Invest In Harrow

Details

Is Harrow Stock a good investment?

Details

What is Harrow Health's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.

You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Return On Equity

0.4484

The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Harrow Historical Balance Sheet

Harrow Health Inventory

11.41 Million

About Harrow Balance Sheet Analysis

Harrow Health Balance Sheet Chart

Total Assets

Total Current Liabilities

Cash And Short Term Investments

Common Stock Shares Outstanding

Harrow Health balance sheet Correlations

Harrow Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Harrow Health balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Non Current Liabilities Total	+ 1.0	Total Liab
Short Long Term Debt Total	+ 1.0	Total Liab
Short Long Term Debt Total	+ 1.0	Non Current Liabilities Total
Net Receivables	+ 1.0	Non Current Assets Total
Non Current Liabilities Total	+ 0.99	Total Assets

Other Stockholder Equity	- 0.96	Retained Earnings
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Inventory	- 0.87	Retained Earnings
Accounts Payable	- 0.85	Retained Earnings
Common Stock	- 0.84	Retained Earnings
Total Current Assets	- 0.84	Retained Earnings